课题基金 / 基金详情

Beta Endorphin Neurons and the Control of Homeostasis

Beta Endorphin Neurons and the Control of Homeostasis
β内啡肽神经元和体内平衡的控制
批准号:
7047877
负责人:
Martin Jeffrey Kelly
金额:
$34.1万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2009-03-31

项目摘要

项目成果

Martin Jeffrey Kelly的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该研究的长期目标是确定雌激素(E2)在下丘脑POMC (β -内啡肽)和多巴胺神经元中作用的快速信号传导机制,以调节生殖、温度调节、应激反应、摄食、动机和奖励等稳态功能;并将这些信息整合到E2膜启动信号的细胞模型中。了解E2的这些新颖、快速的作用及其与基因组作用的关系,将为解决大约5000万需要激素替代治疗的妇女面临的一个根本问题提供见解。E2具有神经保护作用,防止潮热,对情绪和情感有积极影响,对骨质疏松症有保护作用,但会增加患乳腺癌和子宫癌的风险。选择性雌激素受体调节剂(SERMs)在中枢神经系统(CNS)中产生E2的有益作用,但缺乏E2的癌症风险特征,这是迫切需要的。有人认为核雌激素受体ER α和ER β负责E2的所有作用,但我们的研究为一种新的膜相关E2受体在中枢神经系统中介导快速信号传导提供了强有力的证据。受体尚未被确定,其与效应系统耦合的性质也尚未完全了解。我们最近合成了第一个专门针对膜受体的SERM, STX,这将使我们能够严格表征并最终鉴定膜内质网。我们的假设是E2的快速作用是由于它与G蛋白偶联受体结合,激活激酶途径以减弱GABA-B和mu-阿片受体的活性。在这项提议中,我们试图阐明STX激活的细胞级联反应,并进一步表征介导这些作用的受体。我们将使用一系列独特的细胞,分子和化学工具来表征gq偶联E2受体,其与下丘脑神经元信号通路的偶联及其功能后果。具体目的是:(1)测试STX是否使用与E2相同的受体介导的信号通路从POMC和多巴胺神经元的K+通道中解耦GABA-B和mu-阿片受体。(2)检测STX是否会改变下丘脑神经元突触传递关键e2调控转录物亚组的基因表达。(3)检测E2和S TX对内质网α和β缺陷小鼠POMC和多巴胺神经元的快速影响是否存在,并在此基础上建立膜内质网的克隆策略。这些研究不仅将确定对下丘脑神经元快速信号传导至关重要的途径,而且还将允许开发新的SERMs,专门针对参与控制女性体内平衡的关键脑回路。
英文摘要
DESCRIPTION (provided by applicant): The long-range goal of the proposed research is to define the rapid signaling mechanism(s) by which estrogen (E2) acts in hypothalamic POMC (beta-endorphin) and dopamine neurons to modulate homeostatic functions such as reproduction, temperature regulation, stress responses, feeding, motivation and reward; and to incorporate this information into a cellular model of membrane-initiated signaling by E2. Understanding these novel, fast actions of E2 and how they relate to its genomic actions will provide insight into a fundamental problem facing approximately 50 million women in need of hormone replacement therapy. E2 is neuroprotective, prevents hot flushes, has a positive influence on mood and affect, is protective against osteoporosis but increases the risk of breast and uterine cancers. Selective estrogen receptor modulators (SERMs) that produce the beneficial effects of E2 in the central nervous system (CNS) but lack the cancer risk profile of E2 are greatly needed. It has been suggested that the nuclear estrogen receptors ER alpha and ER beta are responsible for all of the actions of E2, but our studies provide strong evidence for a novel membrane-associated E2 receptor that mediates rapid signaling in the CNS. The receptor has not yet been identified nor is the nature of its coupling to effector systems completely understood. We recently synthesized the first SERM, STX, that specifically targets the membrane receptor, which will allow us to rigorously characterize and eventually identify the membrane ER. Our hypothesis is that the rapid effects of E2 are due to its binding to a G protein-coupled receptor that activates kinase pathways to attenuate GABA-B and mu-opioid receptor activity. In this proposal, we seek to elucidate the cellular cascades activated by STX and to further characterize the receptor mediating these effects. We will use a unique range of cellular, molecular and chemical tools to characterize the Gq-coupled E2 receptor, its coupling to signaling pathways in hypothalamic neurons and its functional consequences. The specific aims are: (1) To test whether STX uses the same receptor-mediated signaling pathway as E2 to uncouple GABA-B and mu-opioid receptors from K+ channels in POMC and dopamine neurons. (2) To test whether STX alters gene expression in a sub-group of E2-regulated transcripts that are critical for synaptic transmission in hypothalamic neurons. (3) To test whether the rapid effects of E2 and S TX on POMC and dopamine neurons are present in ER alpha and beta-deficient mice, and based on the results develop a cloning strategy for the membrane ER. These studies will not only identify the pathway(s) that is critical for rapid signaling in hypothalamic neurons but also should allow the development of new SERMs specifically targeting critical brain circuits involved in the control of homeostasis in the female.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of the Neuroprotective STX Receptor in the Brain
  • 批准号:
    10571667
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2022
  • 负责人:
    Martin Jeffrey Kelly
  • 依托单位:
Cross-talk between Leptin and Estrogen Signaling in Hypothalamic Arcuate Neurons
  • 批准号:
    7993025
  • 项目类别:
  • 资助金额:
    $47.83万
  • 财政年份:
    2005
  • 负责人:
    Martin Jeffrey Kelly
  • 依托单位:
Cross-Talk Between Estrogen and Metabolic Hormone Signaling in Arcuate Neurons
  • 批准号:
    9174776
  • 项目类别:
  • 资助金额:
    $44.97万
  • 财政年份:
    2005
  • 负责人:
    Martin Jeffrey Kelly
  • 依托单位:
Cross-Talk between Leptin and Estrogen Signaling in Hypothalamic Arcuate Neurons
海外基金